SELLAS Life Sciences Group, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
SLS chart
What traders are saying about $SLS
Latest postsSELLAS Life Sciences Group, Inc. news
- SLS Stock Turns Green After 3-Day Rout: Five Investors Add Shares As Key AML Trial Nears Final Trigger
Stocktwits ·
- Sellas Life Sciences: Too Many Survivors For Its Own Trial Plan (NASDAQ:SLS)
Seeking Alpha ·
- SLS Stock Heads For Weekly Win: Deutsche Bank’s Stake Boost Draws Attention Ahead Of Q1 Earnings
Stocktwits ·
- SLS Stock Gains Momentum: NVDA, MSFT Investor Loads Up Ahead Of AML Trial Milestone Trigger
Stocktwits ·
- SELLAS Life Sciences Group, Inc. Estimates – NASDAQ:SLS
TradingView ·
- SELLAS Life Sciences Group (SLS) Institutional Ownership 2026 $SLS
MarketBeat ·
- SELLAS Life Sciences Group (SLS) Nears GPS Phase 3 Readout On A Pricey Valuation
Simply Wall Street ·
- SELLAS Life Sciences Group, Inc. (SLS) options chain
Yahoo Finance Australia ·
- SELLAS Life Sciences Group, Inc. • Robinhood Token (SLS) Price Prediction for 2026 to 2031
Bybit ·
- Top Movers: Braze Surges 51% While Sea Limited and GM Slide
Business Upturn ·
- SLS Stock Jumps Overnight: Retail Eyes Huge Potential Buyout As CEO Marks 15 Years
stocktwits.com ·
- SLS Stock Climbs Pre-Market: CEO's Early Anniversary Post Has Retail Bulls Buzzing About Major News
stocktwits.com ·
SELLAS Life Sciences Group, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $0 | $1.0M |
| Net income | -$26.9M | -$30.9M | -$37.3M | -$41.3M |
| Diluted EPS | $-0.25 | $-0.50 | $-1.34 | $-2.13 |
| Total assets (year end) | $78.3M | $19.4M | $6.2M | $20.9M |
| Cash and equivalents (year end) | $71.8M | $13.9M | $2.5M | $17.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About SELLAS Life Sciences Group, Inc.
- Ticker
- SLS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1390478
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Frequently asked questions
What exchange is SELLAS Life Sciences Group, Inc. listed on?
SELLAS Life Sciences Group, Inc. trades on the Nasdaq under the ticker symbol SLS.
What industry is SELLAS Life Sciences Group, Inc. in?
SELLAS Life Sciences Group, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is SELLAS Life Sciences Group, Inc. headquartered?
SELLAS Life Sciences Group, Inc.'s business address on file with the SEC is in New York, NY.
When does SELLAS Life Sciences Group, Inc.'s fiscal year end?
SELLAS Life Sciences Group, Inc.'s fiscal year ends on December 31.
How much revenue did SELLAS Life Sciences Group, Inc. report?
SELLAS Life Sciences Group, Inc. reported $0 in revenue for calendar year 2023, according to its SEC filings.